Lev Goldin

Merck Group, Director, Global Cardiovascular, Metabolism & Endocrinology Franchasie

Lev Goldin is currently a Director in the Strategy & Portfolio Expansion team of the global Cardiovacular, Metabolism and Endocrinology franchise of Merck. In his role Lev is leading the go-to-market model transformation in Europe, pioneering Digital Health and driving strategic decisions for the legacy portfolio of General Medicine Classics.

Lev joined Merck Inhouse Consulting in 2014 and has worked on a number of consulting assignments across Healthcare and Life Science businesses, spending also a portion of his time in the US to support the commercial launch of an anti-PD-L1 immunotherapy in a rare type of skin cancer.

Since 2016, Lev is with the global CM&E franchise where he first worked on an expansion initiative in the fields of Diabetes and Cardiovascular therapeutic areas and assumed later additional responsibilities in the areas of Digital Health, Customer Engagement and strategy for a portfolio of legacy brands.

Lev studied Political Science/International Relations in Germany and Spain and earned a Masters/MBA from EADA Business School in Barcelona and the University of Edinburgh Business School in the UK.

Articles by Lev Goldin

Merck Group’s Internal Management and Leadership Program

A Merck KGaA franchise director on how the 9-month International Management & Leadership Program shaped his career across divisions. See roles at Merck KGaA.